BIGBEAR
PHARMACEUTICAL
Lenalidomide is an immunomodulatory agent and a thalidomide analogue with anti-angiogenic and anti-tumor properties.
AuthenticGuaranteeFast DeliveryPrivacy Indications1. Multiple Myeloma (MM)Newly diagnosed patients: Maintenance therapy after autologous hematopoietic stem cell transplantation (ASCT).Patie···【More】
Update: 21 May,2026Source: BigbearViews: 98
Indications1. Multiple Myeloma (MM)Newly diagnosed patients: Maintenance therapy after autologous hematopoietic stem cell transplantation (ASCT).Patie···【More】
Update: 19 May,2026Source: BigbearViews: 95
Lenalidomide is an oral immunomodulator developed by Celgene Corporation, primarily used to treat hematologic malignancies such as multiple myeloma, m···【More】
Update: 19 May,2026Source: BigbearViews: 95
Indications1. Multiple Myeloma (MM)Newly diagnosed patients: Maintenance therapy after autologous hematopoietic stem cell transplantation (ASCT).Patie···【More】
Update: 19 May,2026Source: BigbearViews: 93
Lenalidomide is an oral immunomodulator developed by Celgene Corporation, primarily used to treat hematologic malignancies such as multiple myeloma, m···【More】
Update: 19 May,2026Source: BigbearViews: 91
Contraindicated Populations for LenalidomidePregnant women are contraindicated.Women of childbearing potential who do not fully meet contraceptive req···【More】
Update: 19 Mar,2026Source: BigbearViews: 108
Mechanism of Action and Therapeutic EffectsLenalidomide is an analog of thalidomide. Although its precise mechanism of action is not fully understood,···【More】
Update: 19 Mar,2026Source: BigbearViews: 107
Copyright2024@ BIGBEAR All right reserved Bigbear | Bigbear Pharmaceutical | Bigbear Laos
